GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q32 Bio Inc (NAS:QTTB) » Definitions » FCF Yield %

Q32 Bio (Q32 Bio) FCF Yield % : -7.15 (As of May. 22, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Q32 Bio FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Q32 Bio's Trailing 12-Month Free Cash Flow is $-25.27 Mil, and Market Cap is $353.55 Mil. Therefore, Q32 Bio's FCF Yield % for today is -7.15%.

The historical rank and industry rank for Q32 Bio's FCF Yield % or its related term are showing as below:

QTTB' s FCF Yield % Range Over the Past 10 Years
Min: -15.66   Med: -11.3   Max: -6.74
Current: -7.15

During the past 3 years, the highest FCF Yield % of Q32 Bio was -6.74%. The lowest was -15.66%. And the median was -11.30%.

QTTB's FCF Yield % is ranked better than
64.52% of 1556 companies
in the Biotechnology industry
Industry Median: -14.16 vs QTTB: -7.15

Q32 Bio's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

Q32 Bio FCF Yield % Historical Data

The historical data trend for Q32 Bio's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q32 Bio FCF Yield % Chart

Q32 Bio Annual Data
Trend Dec21 Dec22 Dec23
FCF Yield %
- - -

Q32 Bio Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial - - - - -28.63

Competitive Comparison of Q32 Bio's FCF Yield %

For the Biotechnology subindustry, Q32 Bio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Q32 Bio's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q32 Bio's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Q32 Bio's FCF Yield % falls into.


Q32 Bio FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Q32 Bio's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-18.682 / 0
=N/A%

Q32 Bio's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-14.551 * 4 / 203.27868
=-28.63%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q32 Bio FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Q32 Bio FCF Yield % Related Terms

Thank you for viewing the detailed overview of Q32 Bio's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Q32 Bio (Q32 Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q32 Bio Inc (NAS:QTTB) » Definitions » FCF Yield %
Comparable Companies
Traded in Other Exchanges
N/A
Address
830 Winter Street, Waltham, MA, USA, 02451
Website
https://www.q32bio.com
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Q32 Bio (Q32 Bio) Headlines

From GuruFocus

Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer

By PRNewswire • 04-03-2024